Generic Plavix (clopidogrel) may not be here to stay

Generic Plavix (clopidogrel) may not be here to stay.

Apotex is challenging a patent that's not due to expire until 2011. They think they have a good case, so they launched a generic BEFORE the case was resolved.

A few days later, Bristol-Myers and Sanofi got an injunction to stop sales of the generic until a final ruling is made.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote